AL
ALXN

AJO LP’s Alexion Pharmaceuticals ALXN Stock Holding History

AJO LP’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-72,421
Closed -$11.3M – 266
2020
Q4 		$11.3M Sell
72,421
-811,393
-92% -$104M 1.17% 17
2020
Q3 		$101M Buy
883,814
+799,514
+948% +$86.3M 1.07% 16
2020
Q2 		$9.46M Buy
84,300
+49,577
+143% +$5.26M 0.09% 198
2020
Q1 		$3.12M Buy
+34,723
New +$3.41M 0.03% 298
2019
Q2 		– Sell
-1,785
Closed -$241K – 778
2019
Q1 		$241K Buy
+1,785
New +$222K ﹤0.01% 634
2015
Q2 		– Sell
-8,960
Closed -$1.55M – 562
2015
Q1 		$1.55M Sell
8,960
-26,760
-75% -$4.84M 0.01% 376
2014
Q4 		$6.61M Sell
35,720
-58,330
-62% -$10.8M 0.03% 253
2014
Q3 		$15.6M Sell
94,050
-435,610
-82% -$71.5M 0.07% 157
2014
Q2 		$82.8M Sell
529,660
-252,640
-32% -$39.9M 0.36% 97
2014
Q1 		$119M Buy
782,300
+726,600
+1,304% +$116M 0.52% 79
2013
Q4 		$7.4M Buy
+55,700
New +$6.68M 0.03% 240

Other funds holding ALXN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

AJO LP's ALXN Position: Q1 2021 in Review

AJO LP sold out of Alexion Pharmaceuticals (ALXN) in Q1 2021, closing a stake of 72,421 shares — an estimated $11.3M sold.

AJO LP first reported a position in ALXN in Q4 2013 and held it in 11 quarters. The position peaked at $119M in Q1 2014. 754 funds tracked by Wall St. Rank hold ALXN as of Q1 2021.

  • AJO LP reported no remaining Alexion Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
  • AJO LP sold 72,421 Alexion Pharmaceuticals shares in Q1 2021, an estimated $11.3M.
  • AJO LP first reported a position in Alexion Pharmaceuticals in Q4 2013 and held it in 11 quarters.
  • AJO LP's Alexion Pharmaceuticals position peaked at $119M in Q1 2014.
  • 754 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q1 2021.

Based on AJO LP's 13F filing for Q1 2021, filed 7 May 2021.